These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer. Simmons AR, Fourkala EO, Gentry-Maharaj A, Ryan A, Sutton MN, Baggerly K, Zheng H, Lu KH, Jacobs I, Skates S, Menon U, Bast RC. Cancer Prev Res (Phila); 2019 Jun; 12(6):391-400. PubMed ID: 30967390 [Abstract] [Full Text] [Related]
10. Risk of malignancy index in the preoperative evaluation of pelvic masses. Obeidat BR, Amarin ZO, Latimer JA, Crawford RA. Int J Gynaecol Obstet; 2004 Jun; 85(3):255-8. PubMed ID: 15145261 [Abstract] [Full Text] [Related]
12. Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients. Li QL, Wang CJ, Qi P, Zhang YX. Clin Transl Oncol; 2017 Oct; 19(10):1260-1267. PubMed ID: 28444641 [Abstract] [Full Text] [Related]
17. Risk of malignancy index in preoperative evaluation of pelvic masses. Ashrafgangooei T, Rezaeezadeh M. Asian Pac J Cancer Prev; 2011 Oct; 12(7):1727-30. PubMed ID: 22126553 [Abstract] [Full Text] [Related]
19. External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses. van den Akker PA, Zusterzeel PL, Aalders AL, Snijders MP, Samlal RA, Vollebergh JH, Kluivers KB, Massuger LF. Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):422-5. PubMed ID: 21824712 [Abstract] [Full Text] [Related]
20. HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses. Abdel-Azeez HA, Labib HA, Sharaf SM, Refai AN. Asian Pac J Cancer Prev; 2010 Dec; 11(1):111-6. PubMed ID: 20593939 [Abstract] [Full Text] [Related] Page: [Next] [New Search]